methotrexate has been researched along with Diabetes Mellitus, Adult-Onset in 28 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (3.57) | 18.2507 |
| 2000's | 5 (17.86) | 29.6817 |
| 2010's | 13 (46.43) | 24.3611 |
| 2020's | 9 (32.14) | 2.80 |
| Authors | Studies |
|---|---|
| Clary, DD; Fanciullo, J; Kiani, R; Reid, AT | 1 |
| Abdellatif, AAH; Aldubayan, MA; Alhowail, AH; Almogbel, YS; Chigurupati, S; Nemala, RA | 1 |
| Bruun, JM; Hundahl, MP; Kjolby, M; Kragstrup, TW; Mikkelsen, RR; Rodríguez-Carrio, J; Torp, CK | 1 |
| Ahmed, S; Carsons, SE; De Leon, J; Kasselman, L; Reiss, AB; Teboul, I | 1 |
| Beburov, MY; Brovkin, AN; Dyachenko, IA; Frolova, AA; Goryacheva, NA; Kaluzhsky, VE; Kazakov, VA; Murashev, AN; Pakhomova, IA; Rasskazova, EA; Sadovnikova, ES; Shaykhutdinova, ER; Slashcheva, GA; Tukhovskaya, EA | 1 |
| Ishiwata, S; Kuroda, M; Migita, K; Miyata, M; Ohira, H; Tasaki, K | 1 |
| Crasta, R; Javed, F; Shakhashiro, M | 1 |
| Baghdadi, LR | 1 |
| Guan, Y; Hao, C; Wang, Q; Wang, Y; Wei, L; Xie, Q | 1 |
| Naka, F; Strober, BE | 1 |
| Bertrand, O; Butman, S; Clearfield, M; Everett, BM; Glynn, RJ; Goldhaber, SZ; Gupta, M; Hasan, A; Iturriaga, E; Johnston, J; Le May, M; Libby, P; MacFadyen, JG; Mam, V; Ofori, C; Paynter, NP; Pradhan, A; Ridker, PM; Rosenberg, Y; Saklayen, M; Seagle, R; Singh, N; Solomon, DH; Tsigoulis, M; Verma, S; Zaharris, E | 1 |
| Ridker, PM | 1 |
| Marc, J; Mlakar, V | 1 |
| Clearfield, M; Everett, BM; Glynn, RJ; Gupta, M; Hasan, AA; Libby, P; Macfadyen, J; Paynter, N; Pradhan, AD; Ridker, PM; Solomon, DH; Zaharris, E | 1 |
| Lai, MS; Lee, MS; Lin, RY | 1 |
| Anthony, MS; Bebchuk, JD; Rowan, CG; Wu, JJ | 1 |
| Abdal, SJ; Afrose, R; Azad, AK; Haq, SA; Rahman, MM; Shazzad, MN | 1 |
| Avery, M; Holmqvist, ME; Michaud, K; Ozen, G; Pedro, S; Wolfe, F | 1 |
| Leong-Poi, H; Pan, Y; Polemidiotis, J; Quan, A; Singh, KK; Teoh, H; Verma, S | 1 |
| Dijkmans, BA; Hamann, D; Heine, RJ; Nurmohamed, MT; Peters, MJ; Simsek, S; van Deutekom, AW; van Eijk, IC | 1 |
| Dann, F; Gottlieb, AB | 1 |
| Billings, SD; Hoschar, AP; McDonnell, JK; Rushing, EC | 1 |
| Ferrazzi, A; Girolomoni, G; Gisondi, P | 1 |
| Akashi, K; Fukagawa, S; Furue, M; Miyamoto, T; Moroi, Y; Sugiyama, A; Takeuchi, S; Yoshimoto, G | 1 |
| Hultcrantz, R; Johannesson, A; Kinnman, N; Lindholm, J; Ros, AM; Rosenberg, P; Urwitz, H | 1 |
| Bowley, R; Chadwick, PR; Houghton, JB; Kelly, AM; McCulloch, AJ; Ng, JP; Shaw, N; Smellie, WS; Stewart, MF; Twomey, PJ | 1 |
| Dean, HA; Minocha, A; Pittsley, RA | 1 |
| Andres-Mateos, E; Arnalich, F; Arnalich, FM; De la Fuente, M; Fernández-Capitán, C; Hernanz, A; López-Maderuelo, D; Montiel, C | 1 |
7 review(s) available for methotrexate and Diabetes Mellitus, Adult-Onset
| Article | Year |
|---|---|
Methotrexate Hepatotoxicity Monitoring Guidelines in Psoriasis and Rheumatoid Arthritis: Is There a Consensus?
Topics: Arthritis, Rheumatoid; Chemical and Drug Induced Liver Injury; Consensus; Diabetes Mellitus, Type 2; Humans; Methotrexate; Psoriasis | 2021 |
Immunomodulatory and immunosuppressive therapies in cardiovascular disease and type 2 diabetes mellitus: A bedside-to-bench approach.
Topics: Animals; Antibodies, Monoclonal, Humanized; Cardiovascular Diseases; Colchicine; Diabetes Mellitus, Type 2; Etanercept; Humans; Hydroxychloroquine; Immunomodulating Agents; Immunosuppression Therapy; Immunosuppressive Agents; Inflammation; Interleukin 1 Receptor Antagonist Protein; Interleukin-1; Interleukin-1beta; Methotrexate; Sulfasalazine | 2022 |
Effect of methotrexate use on the development of type 2 diabetes in rheumatoid arthritis patients: A systematic review and meta-analysis.
Topics: Age Factors; Antirheumatic Agents; Arthritis, Rheumatoid; Diabetes Mellitus, Type 2; Humans; Methotrexate; Risk; Severity of Illness Index | 2020 |
Anticytokine Agents: Targeting Interleukin Signaling Pathways for the Treatment of Atherothrombosis
Topics: Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Atherosclerosis; C-Reactive Protein; Cardiovascular Diseases; CD40 Antigens; CD40 Ligand; Diabetes Mellitus, Type 2; Disease Models, Animal; Hematopoiesis; Humans; Inflammasomes; Interleukin-18; Interleukin-1beta; Interleukin-6; Methotrexate; Mice; NLR Family, Pyrin Domain-Containing 3 Protein; Randomized Controlled Trials as Topic; Renal Insufficiency, Chronic; Signal Transduction; Stroke; Thrombosis; Triggering Receptor Expressed on Myeloid Cells-1 | 2019 |
Comorbidities in patients with psoriasis.
Topics: Arthritis, Psoriatic; Cardiovascular Diseases; Dermatologic Agents; Diabetes Mellitus, Type 2; Humans; Insulin Resistance; Methotrexate; Neoplasms; Obesity; Psoriasis | 2009 |
Metabolic comorbidities and psoriasis.
Topics: Arthritis, Psoriatic; Cardiovascular Diseases; Comorbidity; Diabetes Mellitus, Type 2; Dyslipidemias; Fatty Liver; Humans; Hypertriglyceridemia; Immunosuppressive Agents; Insulin Resistance; Metabolic Syndrome; Methotrexate; Non-alcoholic Fatty Liver Disease; Obesity; Psoriasis; Risk Factors | 2010 |
Best practice in primary care pathology: review 10.
Topics: Blood Glucose; Diabetes Mellitus, Type 2; Drug Monitoring; Female; Glomerular Filtration Rate; Humans; Immunosuppressive Agents; Methotrexate; Patient Selection; Pregnancy; Prenatal Care; Primary Health Care | 2007 |
3 trial(s) available for methotrexate and Diabetes Mellitus, Adult-Onset
| Article | Year |
|---|---|
Methotrexate effects on adenosine receptor expression in peripheral monocytes of persons with type 2 diabetes and cardiovascular disease.
Topics: Adenosine; Cardiovascular Diseases; Cholesterol; Diabetes Mellitus, Type 2; Gene Expression; Humans; Inflammation; Leukocytes, Mononuclear; Methotrexate; Monocytes; Myocardial Infarction; Receptors, Purinergic P1 | 2022 |
Low-Dose Methotrexate for the Prevention of Atherosclerotic Events.
Topics: Aged; Atherosclerosis; C-Reactive Protein; Cardiovascular Diseases; Confidence Intervals; Coronary Artery Disease; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Interleukin-1beta; Interleukin-6; Male; Metabolic Syndrome; Methotrexate; Middle Aged; Myocardial Infarction; Proportional Hazards Models; Statistics, Nonparametric; Stroke; Transaminases | 2019 |
Rationale and design of the Cardiovascular Inflammation Reduction Trial: a test of the inflammatory hypothesis of atherothrombosis.
Topics: Algorithms; Anti-Inflammatory Agents; Atherosclerosis; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Humans; Inflammation; Metabolic Syndrome; Methotrexate; Myocardial Infarction; Research Design | 2013 |
18 other study(ies) available for methotrexate and Diabetes Mellitus, Adult-Onset
| Article | Year |
|---|---|
Effects of CMF and MET on glutamate and dopamine levels in the brain, and their impact on cognitive function.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Brain; Breast Neoplasms; Cognition; Cyclophosphamide; Diabetes Mellitus, Type 2; Dopamine; Female; Fluorouracil; Glutamic Acid; Humans; Metformin; Methotrexate; Rats | 2022 |
AICAR Improves Outcomes of Metabolic Syndrome and Type 2 Diabetes Induced by High-Fat Diet in C57Bl/6 Male Mice.
Topics: AMP-Activated Protein Kinases; Animals; Body Weight; Diabetes Mellitus, Type 2; Diet, High-Fat; Male; Metabolic Syndrome; Methotrexate; Mice; Mice, Inbred C57BL; Ribonucleosides | 2022 |
Hepatic failure in a patient with rheumatoid arthritis treated with methotrexate: A case report.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Diabetes Mellitus, Type 2; Female; Humans; Liver Failure; Methotrexate; Non-alcoholic Fatty Liver Disease | 2023 |
Certolizumab-induced liver injury: as assessed for causality by the updated RUCAM.
Topics: Abdominal Pain; Certolizumab Pegol; Chemical and Drug Induced Liver Injury; Chemical and Drug Induced Liver Injury, Chronic; Diabetes Mellitus, Type 2; Female; Humans; Methotrexate | 2023 |
Diabetes is a risk factor for high-dose methotrexate-associated AKI in lymphoma patients.
Topics: Acute Kidney Injury; Adult; Aged; Antimetabolites, Antineoplastic; Diabetes Mellitus, Type 2; Female; Glomerular Filtration Rate; Humans; Hypertension; Logistic Models; Lymphoma; Male; Methotrexate; Middle Aged; Retrospective Studies; Risk Factors | 2020 |
Methotrexate treatment of generalized granuloma annulare: a retrospective case series.
Topics: Aged; Alopecia; Diabetes Mellitus, Type 2; Female; Gastrointestinal Diseases; Granuloma Annulare; Humans; Male; Methotrexate; Middle Aged; Retrospective Studies; Thyroid Diseases; Treatment Outcome | 2018 |
Highlights from the latest pharmacogenomic genome-wide association studies.
Topics: Animals; Antimetabolites, Antineoplastic; Antineoplastic Agents, Hormonal; Biomedical Research; Breast Neoplasms; Cell Cycle Proteins; Chromosomes, Human, Pair 10; Diabetes Mellitus, Type 2; DNA-Binding Proteins; Drug Industry; Exons; Female; Genetic Loci; Genetic Variation; Genome-Wide Association Study; Humans; Male; Metabolism; Metformin; Methotrexate; Neoplasm Proteins; Organic Anion Transporters; Polymorphism, Single Nucleotide; Protein Serine-Threonine Kinases; Tamoxifen; Tumor Suppressor Proteins | 2013 |
Increased risk of diabetes mellitus in relation to the severity of psoriasis, concomitant medication, and comorbidity: a nationwide population-based cohort study.
Topics: Adult; Age Distribution; Aged; Case-Control Studies; Cohort Studies; Comorbidity; Confidence Intervals; Databases, Factual; Diabetes Mellitus, Type 2; Female; Humans; Kaplan-Meier Estimate; Male; Methotrexate; Middle Aged; Prevalence; Prognosis; Proportional Hazards Models; Psoriasis; Risk Assessment; Severity of Illness Index; Sex Distribution; Statistics, Nonparametric; Taiwan; Thiazides | 2014 |
No association between TNF inhibitor and methotrexate therapy versus methotrexate in changes in hemoglobin A1C and fasting glucose among psoriasis, psoriatic arthritis, and rheumatoid arthritis patients.
Topics: Aged; Antirheumatic Agents; Arthritis, Psoriatic; Arthritis, Rheumatoid; Blood Glucose; Cohort Studies; Diabetes Mellitus, Type 2; Fasting; Female; Glycated Hemoglobin; Humans; Male; Methotrexate; Middle Aged; Psoriasis; Retrospective Studies; Tumor Necrosis Factor-alpha | 2015 |
Scleredema Diabeticorum - A Case Report.
Topics: Combined Modality Therapy; Dermatologic Agents; Diabetes Mellitus, Type 2; Diagnosis, Differential; Humans; Male; Methotrexate; Middle Aged; PUVA Therapy; Scleredema Adultorum | 2015 |
Risk of diabetes mellitus associated with disease-modifying antirheumatic drugs and statins in rheumatoid arthritis.
Topics: Abatacept; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Hydroxychloroquine; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Incidence; Longitudinal Studies; Male; Methotrexate; Middle Aged; Proportional Hazards Models; Protective Factors; Risk Factors; United States | 2017 |
Cardiovascular inflammation is reduced with methotrexate in diabetes.
Topics: Animals; Cardiovascular Diseases; Diabetes Complications; Diabetes Mellitus, Type 2; Inflammation; Methotrexate; Mice; Mice, Transgenic | 2017 |
Methotrexate and its effect on the anti-GAD titre in two patients with rheumatoid arthritis and diabetes mellitus.
Topics: Aged; Arthritis, Rheumatoid; Autoantibodies; Diabetes Mellitus, Type 2; Female; Glutamate Decarboxylase; Humans; Immunosuppressive Agents; Methotrexate; Middle Aged | 2008 |
Iatrogenic oral hairy leukoplakia: report of two cases.
Topics: Aged; Anti-Infective Agents; Anti-Inflammatory Agents; Antifungal Agents; Arthritis, Rheumatoid; Clobetasol; Dapsone; Dermatologic Agents; Dexamethasone; Diabetes Mellitus, Type 2; Epstein-Barr Virus Infections; Female; Fluconazole; Humans; Immunocompromised Host; Leukoplakia, Hairy; Lichen Planus; Methotrexate; Nystatin; Prednisone; Zinc Oxide | 2011 |
Case of insulin edema occurring during intensive insulin therapy after bone marrow transplantation.
Topics: Bone Marrow Transplantation; Diabetes Mellitus, Type 2; Edema; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Insulin; Leg; Methotrexate; Middle Aged; Myelodysplastic Syndromes; Prednisolone; Skin Diseases; Tacrolimus; Treatment Outcome | 2012 |
Psoriasis patients with diabetes type 2 are at high risk of developing liver fibrosis during methotrexate treatment.
Topics: Adult; Aged; Alcohols; Dermatologic Agents; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Female; Fibrosis; Humans; Liver; Male; Methotrexate; Middle Aged; Psoriasis; Risk Factors | 2007 |
Liver cirrhosis in rheumatoid arthritis patients treated with long-term methotrexate.
Topics: Adult; Aged; Arthritis, Rheumatoid; Biopsy; Diabetes Mellitus, Type 2; Female; Humans; Liver Cirrhosis; Long-Term Care; Male; Methotrexate; Middle Aged; Retrospective Studies | 1993 |
Intracellular glutathione deficiency is associated with enhanced nuclear factor-kappaB activation in older non-insulin dependent diabetic patients.
Topics: Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Diabetes Mellitus, Type 2; DNA; Doxorubicin; Electrophoretic Mobility Shift Assay; Etoposide; Female; Glutathione; Humans; Interleukin-6; Male; Methotrexate; NF-kappa B; Sulfhydryl Compounds | 2001 |